Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Deirdre BeVard
Elligo Health Research, a clinical research infrastructure provider of clinical research infrastructure (CRI) services and technologies, has hired Deirdre BeVard as chief operating officer.
Clinipace Worldwide, a global full-service CRO, has named industry veteran Steve Skolsky to its Board of Directors. Steve holds 30 years of experience in the pharma, biotech, CRO, and health care services sectors.
Karolinska Development's portfolio company Modus Therapeutics AB, a Nordic life sciences investment company, has recruited Professor Thomas Knittel as its new Chief Medical Officer. Thomas brings along 10 years of clinical and over 15 years of experience from research and development, medical affairs, and marketing within the pharmaceutical industry.
Business News
Cmed announced its one-year anniversary of the launch of encapsia, an innovative cloud-based clinical data suite of apps that helps biotech and pharma sponsors transform the way data is captured, monitored, and reviewed in clinical trials.
OmniComm Systems, Inc., a global provider of clinical data management technology, announced that it has received certification approval from the U.S. Department of Commerce for the EU-U.S. Privacy Shield Framework program and the Swiss-U.S. Privacy Shield Framework, the successors to the U.S.-EU and U.S.-Swiss Safe Harbor Frameworks.
Clintec, a global full service CRO, has been presented with the Queens Award for Enterprise 2017, in the
Clintec receives Queens Award for Enterprise 2017
category of International Trade, the highest business accolade that can be granted to any business operating within the UK.
Forte, an industry developer of clinical research solutions, announced the launch of its new brand identity and redesigned website, ForteResearch.com. The new website launch represents their vision for the future as a company.
Certara, a global company in model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. They are the 36th biopharmaceutical and 11th Japanese pharmaceutical company to join the Consortium.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
